Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

Myomo Lowers FY2025 Sales Guidance from $50.000M-$53.000M to $40.000M-$42.000M vs $49.208M Est

Author: Benzinga Newsdesk | August 11, 2025 03:13pm
Myomo (AMEX:MYO) lowers FY2025 sales outlook from $50.000 million-$53.000 million to $40.000 million-$42.000 million vs $49.208 million estimate.

Posted In: MYO

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist